Theresa Balber

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Pharmaceutical sciences in the heart of Europe: Highlights from the joint EUFEPS-ÖPhG meeting.

Pharmaceutical sciences in the heart of Europe: Highlights from the joint EUFEPS-ÖPhG meeting.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: August 12, 2026

R3ACT: An Oxygen-Controlled Biosensor-Based NAM to Support Animal-Free Chemical Safety Assessment.

R3ACT: An Oxygen-Controlled Biosensor-Based NAM to Support Animal-Free Chemical Safety Assessment.

Journal: NAM journal

Published: May 15, 2026

Mn(II)-Tagged DOTA-Modified Sugar-Based Biopolymers as Gadolinium-Free Contrast Agents for Magnetic Resonance Imaging.

Mn(II)-Tagged DOTA-Modified Sugar-Based Biopolymers as Gadolinium-Free Contrast Agents for Magnetic Resonance Imaging.

Journal: Pharmaceutics

Published: March 06, 2026

PET/MRI with 89Zr-labelled antibodies provides insights into altered antibody pharmacokinetics in the chick embryo model.

PET/MRI with 89Zr-labelled antibodies provides insights into altered antibody pharmacokinetics in the chick embryo model.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: December 19, 2025

Site-Selectively Functionalized Albumin with DFO*Maleimide for 89Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in Mice.

Site-Selectively Functionalized Albumin with DFO*Maleimide for 89Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in Mice.

Journal: Journal of medicinal chemistry

Published: June 17, 2025

Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [99mTc]Tc-PSMA-I&S and [111In]In-RM2.

Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [99mTc]Tc-PSMA-I&S and [111In]In-RM2.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 27, 2025

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Journal: Neuro-oncology

Published: November 18, 2024

Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQ.

Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQ.

Journal: EJNMMI radiopharmacy and chemistry

Published: October 15, 2024

An in vivo tumour organoid model based on the chick embryonic chorioallantoic membrane mimics key characteristics of the patient tissue: a proof-of-concept study.

An in vivo tumour organoid model based on the chick embryonic chorioallantoic membrane mimics key characteristics of the patient tissue: a proof-of-concept study.

Journal: EJNMMI research

Published: August 05, 2024

The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells.

The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells.

Journal: Nuclear medicine and biology

Published: July 31, 2024

Quantitative accuracy of preclinical in ovo PET/MRI: influence of attenuation and quantification methods.

Quantitative accuracy of preclinical in ovo PET/MRI: influence of attenuation and quantification methods.

Journal: EJNMMI physics

Published: May 22, 2024

Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103.

Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: March 12, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026